Shilling V, Jenkins V, Fallowfield L, Howell A
CRC Psychosocial Oncology Group, University of Sussex, UK.
Breast. 2001 Dec;10(6):484-91. doi: 10.1054/brst.2001.0311.
Recent research suggests that oestrogen may play an important role in cognition. Epidemiological and experimental studies of hormone replacement therapy in post-menopausal women suggest that oestrogen may be important to verbal memory in particular, as well as other cognitive functions such as attention and processing speed. Some studies have also suggested that HRT may have a beneficial effect for Alzheimer's disease, both in the prevention or delay of onset and that it is also of therapeutic benefit to patients in whom the disease is established. The use of selective oestrogen receptor modulators (SERMs) and other hormonal therapies for the treatment of breast cancer is common, yet few studies have examined the possible cognitive effects of this form of treatment. Several studies have shown cognitive decline in women receiving treatment for breast cancer, but the focus has been on the effects of chemotherapy. Further confusion has resulted from the diverse methodologies used in the existing literature. A pilot study to develop a suitable cognitive battery of tests for the evaluation of cognitive function in women receiving hormonal therapy for the treatment or prevention of breast cancer is introduced.
近期研究表明,雌激素可能在认知过程中发挥重要作用。对绝经后女性激素替代疗法的流行病学和实验研究表明,雌激素可能对言语记忆尤其重要,对注意力和处理速度等其他认知功能也很重要。一些研究还表明,激素替代疗法对阿尔茨海默病可能具有有益作用,既可以预防或延缓发病,对已确诊该病的患者也具有治疗益处。使用选择性雌激素受体调节剂(SERM)和其他激素疗法治疗乳腺癌很常见,但很少有研究考察这种治疗方式可能产生的认知影响。多项研究显示,接受乳腺癌治疗的女性存在认知能力下降的情况,但重点一直放在化疗的影响上。现有文献中使用的方法多种多样,这进一步造成了混淆。本文介绍了一项初步研究,该研究旨在开发一套合适的认知测试组合,用于评估接受激素疗法治疗或预防乳腺癌的女性的认知功能。